Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse

Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse

Bibliographic Details
Main Authors:	Christopher N. Nguyen, BA, Swaminathan P. Iyer, MD, Roberto N. Miranda, MD, Carlos A. Torres-Cabala, MD, Jonathan L. Curry, MD, Penny Fang, MD, Valencia D. Thomas, MD, Auris O. Huen, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	JAAD Case Reports
Subjects:	ALCL C-ALCL CD30+ LPD cutaneous lymphoma CTCL
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621006366

Similar Items

Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy
by: Takashi Onaka, et al.
Published: (2018-05-01)

Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries
by: Chalid Assaf, et al.
Published: (2021-12-01)

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma—Experience from an Indian Center
by: Muthiah Vaikundaraja Indhuja, et al.

Cardiac anaplastic large cell lymphoma in an 8-year old boy
by: Melchior Lauten, et al.
Published: (2014-01-01)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
by: Suzanne D. Turner
Published: (2017-10-01)

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BI-ALCL)
by: R. Sabetta, et al.
Published: (2020-03-01)

Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma
by: Beatrice Belmonte, et al.
Published: (2021-06-01)

Flow Cytometry Analysis in Breast Implant-Associated Anaplastic Large Cell Lymphoma: Three Case Reports
by: Veronica Davanzo, et al.
Published: (2024-03-01)

Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment
by: Xin-Rui Zhang, et al.
Published: (2022-03-01)

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL
by: Gavin D. Garland, et al.
Published: (2021-12-01)

Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis
by: Guillermo Ramos-Gallardo, et al.
Published: (2017-01-01)

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
by: Ivonne A. Montes-Mojarro, et al.
Published: (2018-04-01)

Advanced-stage breast implant-associated large cell anaplastic lymphoma: A rare case of mass-like bilateral disease with axillary involvement
by: I. Barco, et al.
Published: (2023-03-01)

Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population
by: Shruti Zaveri, et al.
Published: (2020-07-01)

Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma
by: Giulia Arosio, et al.
Published: (2021-09-01)

Anaplastic large cell lymphoma: A great mimic on cytology
by: Mona A Agnihotri, et al.
Published: (2017-01-01)

Updates in pathobiological aspects of anaplastic large cell lymphoma
by: Rui Wu, et al.
Published: (2023-09-01)

B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
by: Zhenguo Zi, et al.
Published: (2020-12-01)

ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
by: Yu Q, et al.
Published: (2022-10-01)

Comprehensive Evaluation of the Current Knowledge on Breast Implant Associated-Anaplastic Large Cell Lymphoma
by: Hyokyung Yoo, et al.
Published: (2022-03-01)

Extreme Hypoglycaemia in Anaplastic Large Cell Lymphoma
by: Lidor Akavia, et al.
Published: (2017-03-01)

A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
by: Kazunori Kawasoe, et al.
Published: (2023-10-01)

Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial
by: Lara Mussolin, et al.
Published: (2020-09-01)

Brentuximab vedotin use in pediatric anaplastic large cell lymphoma
by: Jennifer E. Agrusa, et al.
Published: (2023-05-01)

Breast Reconstruction after Breast Implant-Associated Anaplastic Large Cell Lymphoma Treatment: A Case Report and Literature Review
by: Won-Seob Lee, et al.
Published: (2023-02-01)

Anaplastic large cell lymphoma of breast masquerading suppurative mastitis on cytology
by: Sailuja Maharjan, et al.
Published: (2022-08-01)

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
by: Ritsuko Nakai, et al.
Published: (2019-12-01)

Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
by: Yuan Wang, et al.
Published: (2022-02-01)

Breast lymphomas, breast implants and capsules The timeline of BIA-ALCL with respect to surgical consent: the UK perspective
by: Keith Allison, et al.
Published: (2022-12-01)

Our Experience in Diagnosing and Treating Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
by: Gon Shoham, et al.
Published: (2024-01-01)

Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma
by: Yichen Wang, et al.
Published: (2022-01-01)

Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL
by: Benedetto Longo, et al.
Published: (2022-12-01)

Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma
by: Camille Daugrois, et al.
Published: (2021-11-01)

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
by: Vijay Kumar Singh, et al.
Published: (2019-09-01)

Incidental Bystander or Essential Culprit: A Systematic Review of Bacterial Significance in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma
by: Jose A. Foppiani, et al.
Published: (2023-12-01)

Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology
by: Piero Di Battista, et al.
Published: (2021-05-01)

Therapeutic challenges in peripheral T-cell lymphoma
by: Yunpeng Luan, et al.
Published: (2024-01-01)

Isoimperatorin therapeutic effect against aluminum induced neurotoxicity in albino mice
by: Peramaiyan Rajendran, et al.
Published: (2023-04-01)

Evaluation of antioxidant and antimutagenic activities of aluminum chloride
by: İnci Rana Karaca, et al.
Published: (2019-05-01)

ALK inhibitors, a pharmaceutical perspective
by: Arturo eGalvani, et al.
Published: (2012-02-01)